Arama Sonuçları - Mark Sculpher
- Gösterilen 1 - 20 sonuçlar arası kayıtlar. 53
- Sonraki Sayfaya Git
-
1
-
2
Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model Yazar: Richard Pitman, Lisa Nagy, Mark Sculpher
Baskı/Yayın Bilgisi 2012Artigo -
3
-
4
Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales Yazar: Richard Pitman, Lisa J. White, Mark Sculpher
Baskı/Yayın Bilgisi 2011Artigo -
5
Cost-effectiveness of laparoscopic fundoplication <i>versus</i> continued medical management for the treatment of gastro-oesophageal reflux disease based on long-term follow-up of... Yazar: Rita Faria, Laura Bojke, David Epstein, Belén Corbacho, Mark Sculpher
Baskı/Yayın Bilgisi 2013Artigo -
6
Economic analysis of the prevalence and clinical and economic burden of medication error in England Yazar: Rachel Elliott, Elizabeth Camacho, Dina Janković, Mark Sculpher, Rita Faria
Baskı/Yayın Bilgisi 2020Artigo -
7
-
8
The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy. Yazar: L.C. Brown, Janet T. Powell, SG Thompson, David Epstein, Mark Sculpher, RM Greenhalgh
Baskı/Yayın Bilgisi 2012Artigo -
9
-
10
-
11
-
12
Long-term cost-effectiveness analysis of endovascular <i>versus</i> open repair for abdominal aortic aneurysm based on four randomized clinical trials Yazar: David Epstein, Mark Sculpher, Janet T. Powell, Simon G. Thompson, Louise Brown, Roger M. Greenhalgh
Baskı/Yayın Bilgisi 2014Artigo -
13
Value for money and the Quality and Outcomes Framework in primary care in the UK NHS Yazar: Simon Walker, Anne Mason, Karl Claxton, Richard Cookson, Elisabeth Fenwick, Robert Fleetcroft, Mark Sculpher
Baskı/Yayın Bilgisi 2010Revisão -
14
Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non–ST-segment elevation myocardial infarction Yazar: Joseph Kim, Robert Henderson, Stuart Pocock, Tim Clayton, Mark Sculpher, Keith A.A. Fox
Baskı/Yayın Bilgisi 2005Artigo -
15
Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic a... Yazar: Heather L. Van Epps, Laura Ginnelly, Martin Utley, T Southwood, S Gallivan, Mark Sculpher, Pick N Woo
Baskı/Yayın Bilgisi 2005Artigo -
16
EOS 2D/3D X-ray imaging system: a systematic review and economic evaluation Yazar: Claire McKenna, Ros Wade, Rita Faria, Huiqin Yang, Lisa Stirk, N Gummerson, Mark Sculpher, Nerys Woolacott
Baskı/Yayın Bilgisi 2012Revisão -
17
Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation Yazar: Fiona Paton, Mike Paulden, Duncan Chambers, Morag Heirs, Steve Duffy, Jennifer M. Hunter, Mark Sculpher, Nerys Woolacott
Baskı/Yayın Bilgisi 2010Revisão -
18
Sugammadex for reversal of neuromuscular block after rapid sequence intubation: a systematic review and economic assessment Yazar: Duncan Chambers, Mike Paulden, Fiona Paton, Morag Heirs, Steve Duffy, Jennifer M. Hunter, Mark Sculpher, Nerys Woolacott
Baskı/Yayın Bilgisi 2010Revisão -
19
Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS) Yazar: Rita Faria, Marta Soares, Eldon Spackman, Hashim U. Ahmed, Louise Brown, Richard Kaplan, Mark Emberton, Mark Sculpher
Baskı/Yayın Bilgisi 2017Artigo -
20
The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis Yazar: Yolanda Bravo Vergel, Neil Hawkins, K. Claxton, Christian Asseburg, Stephen Palmer, Nerys Woolacott, Ian N Bruce, Mark Sculpher
Baskı/Yayın Bilgisi 2007Revisão
Arama Araçları:
İlgili Konular
Medicine
Internal medicine
Cost effectiveness
Randomized controlled trial
Risk analysis (engineering)
Surgery
Pathology
Political science
Law
Quality-adjusted life year
Clinical trial
Nursing
Physical therapy
Disease
MEDLINE
Biology
Intensive care medicine
Alternative medicine
Economics
Psychiatry
Quality of life (healthcare)
Cardiology
Confidence interval
Environmental health
Systematic review
Cancer
Cost–benefit analysis
Ecology
Population
Cost-effectiveness analysis